Status:
UNKNOWN
Methylation Status of CD44 Promoter Region in Primary Lung Cancer
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Non-Small Cell Lung Cancer
Eligibility:
All Genders
Brief Summary
This project is to study the methylation status of the transcriptional regulatory region of CD44 gene in surgically resected NSCLC specimens and normal lung tissue, correlate the methylation status of...
Detailed Description
CD44 is a cell surface receptor for the extracellular matrix hyaluronan. It mediates adhesion of cells to the extracellular matrix. Its ability to organize extracellular matrix into a medium is also u...
Eligibility Criteria
Inclusion
- Non-small cell lung cancer
Exclusion
- No
Key Trial Info
Start Date :
August 1 2005
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00173680
Start Date
August 1 2005
Last Update
November 24 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Laboratory Medicine, Nation Taiwan University Hospital
Taipei, Taiwan